beta
CORI
Corium International Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Corium International Inc is a commercial stage biopharmaceutical company. The company develops, manufactures and commercializes specialty pharmaceutical products that leverage its experience in transdermal and transmucosal delivery systems.
Market Cap: 484 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.coriumgroup.com
Shares Outstanding: 36.1 Million
Float: 35.9 Million
Dividend: 0.0 (0.0%)
Beta: 1.697106
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 835 trading days
From: 2015-08-03 To: 2018-11-26
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|